Skip to Content

The Medical Letter on Drugs and Therapeutics
Objective, peer-reviewed evaluations of new FDA-approved drugs, and new information on previously approved drugs.
July 21, 2014 (Issue 1447)
  • Dalbavancin (Dalvance) for Skin and Skin Structure Infections
  • Drugs for Inflammatory Bowel Disease
  • Sucroferric Oxyhydroxide (Velphoro) for Hyperphosphatemia
  • A Transcutaneous Electrical Nerve Stimulation Device (Cefaly) for Migraine
  • Drugs for Osteoarthritis
Treatment Guidelines from The Medical Letter
Unbiased reviews of drug classes used to treat common disorders. Includes the doses, adverse effects and the recommendations of expert reviewers.
June 2014 (Issue 142)
  • Vaccines recommended for adults residing in the US are reviewed here. Vaccines for travel have been reviewed separately.

    Eight vaccines are currently recommended by the US Advisory Committee on Immunization Practices (ACIP) for routine use in adults at various ages: influenza, tetanus-diphtheria alone (Td) or combined with acellular pertussis (Tdap), human papillomavirus (HPV), varicella, zoster, measles/mumps/rubella (MMR), and pneumococcal polysaccharide. For some patients, pneumococcal conjugate, hepatitis A, hepatitis B... [more]